Skip to content
  • Home
  • About
  • Products
    • Abramit 250
    • Abramit 500
    • Acamit
    • Capebax
    • Crizomits
    • Dasomit 50
    • Dasomit 100
    • Erlomits
    • Fludamits
    • Imatrex
    • Leucovex
    • Mexotrex1000
    • Mitsigem
    • Mitsigem200
    • Mitsogef
    • Mitsotrex 500
    • Mitsotrex50
    • Paclomits 30
    • Paclomits 100
    • Paclomits 260
    • Pazomit 200
    • Pazomit 400
    • Regomit
  • Blog
  • Contact
Oncolife.cdr
Enquiry

Day: October 4, 2026

How Capecitabine 500mg Benefits Cancer Patients as an Oral Chemotherapy Option and Why It Drives Franchise Demand

Capecitabine 500mg Franchise

Cancer treatment has undergone enormous changes with the introduction of oral chemotherapy drugs that can be implemented into many different therapy protocols. Capecitabine 500 mg is one such oral anti-cancer drug that, in a process occurring in vivo, is metabolized into the anti-cancer compound 5-fluorouracil. It is indicated for use as an anti-cancer drug for […]

MITS Oncology specializes in oncology and formulations focused on modern cancer treatment.

Facebook Instagram Linkedin

Our Products

  • Abramit 250
  • Abramit 500
  • Acamit
  • Capebax
  • Crizomits
  • Dasomit 50
  • Dasomit 100
  • Erlomits
  • Fludamits
  • Imatrex
  • Leucovex
  • Mexotrex1000
  • Mitsigem
  • Mitsigem200
  • Mitsogef
  • Mitsotrex 500
  • Mitsotrex50
  • Paclomits 30
  • Paclomits 100
  • Paclomits 260
  • Pazomit 200
  • Pazomit 400
  • Regomit

Contact Us

  • +91 90413 28328
  • +91 98759 15603
  • +91 70874 04024
  • info@mitsoncology.com
  • Plot No. 331, Phase 1 Industrial Area, Panchkula, Haryana - 134113.
  • Privacy Policy
  • Terms & Conditions
  • Blog

© 2026 Mits Oncolife. All rights reserved. | Powered ♥ by: WebClixs

    Request a Quote